SA
Sign upLog In
ARWR

ARWR Stock-Based Compensation

$70.00MTTM · USD

Period ending:

QuarterlyTTMAnnualChart Studio →
ARWR FY Stock-Based CompUSD
ARWR FY Stock-Based Comp1997-09-30: $0.001998-09-30: $0.001999-09-30: $0.002000-09-30: $0.002001-09-30: $0.002002-09-30: $0.002003-09-30: $0.002004-09-30: $0.002005-09-30: $0.002006-09-30: $0.002007-09-30: $0.002008-09-30: $0.002009-09-30: $2.68M2010-09-30: $1.42M2011-09-30: $1.38M2012-09-30: $1.24M2013-09-30: $1.54M2014-09-30: $5.70M2015-09-30: $10.23M2016-09-30: $11.60M2017-09-30: $7.89M2018-09-30: $8.45M2019-09-30: $12.39M2020-09-30: $43.38M2021-09-30: $76.67M2022-09-30: $120.89M2023-09-30: $78.13M2024-09-30: $73.97M2025-09-30: $63.37M$120.89M$0.00
1997-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ARWR stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 29 observations from Sep 30, 1997 to Sep 30, 2025.

Arrowhead Pharmaceuticals Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
63,366,000
73,968,000
78,130,000
120,893,000
76,673,000
43,383,000
12,393,000
8,454,607
7,891,595
11,595,816
10,232,897
5,696,173
1,536,271
1,241,404
1,376,921
1,424,293
2,676,170
0
0
0
0
0
0
0
0
0
0
0
0

Compare stock-based compensation

All ARWR financial metrics · ARWR stock overview · How to interpret financial metrics

Explore More

Stock Comparison

Compare equities side by side

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.